scispace - formally typeset
Open AccessJournal ArticleDOI

Alzheimer’s Disease: Past, Present, and Future

Reads0
Chats0
TLDR
A lineage of work beginning with Alzheimer’s own writings and drawings is reviewed, then jump to the modern era beginning in the 1970s and early 1980s and a sampling of neuropsychological and other contextual work from each ensuing decade is provided.
Abstract
Although dementia has been described in ancient texts over many centuries (e.g., "Be kind to your father, even if his mind fail him." - Old Testament: Sirach 3:12), our knowledge of its underlying causes is little more than a century old. Alzheimer published his now famous case study only 110 years ago, and our modern understanding of the disease that bears his name, and its neuropsychological consequences, really only began to accelerate in the 1980s. Since then we have witnessed an explosion of basic and translational research into the causes, characterizations, and possible treatments for Alzheimer's disease (AD) and other dementias. We review this lineage of work beginning with Alzheimer's own writings and drawings, then jump to the modern era beginning in the 1970s and early 1980s and provide a sampling of neuropsychological and other contextual work from each ensuing decade. During the 1980s our field began its foundational studies of profiling the neuropsychological deficits associated with AD and its differentiation from other dementias (e.g., cortical vs. subcortical dementias). The 1990s continued these efforts and began to identify the specific cognitive mechanisms affected by various neuropathologic substrates. The 2000s ushered in a focus on the study of prodromal stages of neurodegenerative disease before the full-blown dementia syndrome (i.e., mild cognitive impairment). The current decade has seen the rise of imaging and other biomarkers to characterize preclinical disease before the development of significant cognitive decline. Finally, we suggest future directions and predictions for dementia-related research and potential therapeutic interventions. (JINS, 2017, 23, 818-831).

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Current and Future Treatments in Alzheimer Disease: An Update.

TL;DR: A review of disease-modifying therapies for Alzheimer disease can be found in this paper, where the authors discuss potential disease modifying therapies that are currently being studied and potential individualized therapeutic frameworks that can be proved beneficial for patients with AD.
Journal ArticleDOI

New Insights Into the Pathogenesis of Alzheimer's Disease.

TL;DR: The neuropathology of AD was reviewed and new insights in the pathogenesis of AD were discussed, including gamma oscillations, prion transmission, cerebral vasoconstriction, growth hormone secretagogue receptor 1α-mediated mechanism, and infection.
Journal ArticleDOI

Layer-Wise Relevance Propagation for Explaining Deep Neural Network Decisions in MRI-Based Alzheimer's Disease Classification.

TL;DR: It is concluded that LRP might have a high potential to assist clinicians in explaining neural network decisions for diagnosing AD (and potentially other diseases) based on structural MRI data.
Journal ArticleDOI

TGF-β Signaling in Cellular Senescence and Aging-Related Pathology.

TL;DR: The findings regarding these diseases suggest that the impairment of TGF-β signaling in certain cell types and the upregulation of T GF-β ligands contribute to cell degeneration, tissue fibrosis, inflammation, decreased regeneration capacity, and metabolic malfunction.
Journal ArticleDOI

Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research.

TL;DR: Diagnostic and statistical advances, which have been recently integrated in clinical trials, are relevant to the recent failures of studies of disease-modifying treatments for AD.
References
More filters
Journal ArticleDOI

“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

TL;DR: A simplified, scored form of the cognitive mental status examination, the “Mini-Mental State” (MMS) which includes eleven questions, requires only 5-10 min to administer, and is therefore practical to use serially and routinely.

A practical method for grading the cognitive state of patients for the clinician

TL;DR: The Mini-Mental State (MMS) as mentioned in this paper is a simplified version of the standard WAIS with eleven questions and requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
Journal ArticleDOI

Diagnostic and Statistical Manual of Mental Disorders

TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Journal ArticleDOI

Clinical diagnosis of Alzheimer's disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

TL;DR: The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.
Related Papers (5)